Properties |
Information |
PhytoCAT-ID |
PhytoCAT-581 |
Phytochemical name or plant extracts |
Aglaiabbreviatin E (AA-5) |
PMID |
29050217 |
Literature evidence |
After 48 h treatment, AA-5 (1) and AA-6 (2) significantly increased mitochondrial-mediated apoptosis by enhancing reactive oxygen species (ROS) with depressed mitochondrial membrane potential and caspase-9 activities. |
IUPAC name |
(5R,8R,9R,10R,13R,14R,17S)-17-[(4E)-6-hydroxy-6-methylhepta-1,4-dien-2-yl]-4,4,8,10,14-pentamethyl-1,2,5,6,7,9,11,12,13,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one |
Phytochemicals’ class or type of plant extracts |
Triterpenoid |
Source of phytochemicals or plant Extracts |
Aglaia abbreviata |
|
Geographical availability |
Andaman Is., Assam, Bangladesh, Borneo, Cambodia, China South-Central, China Southeast, Hainan, India, Jawa, Laos, Lesser Sunda Is., Malaya, Maluku, New Caledonia, New Guinea, Philippines, Queensland, Samoa, Sri Lanka, Sulawesi, Sumatera, Taiwan, Thailand, Vanuatu, Vietnam, Western Australia |
Plant parts |
Stem |
Other cancers |
Breast cancer |
Target gene or protein |
Caspase 9 |
Gene or Protein evidence |
After 48 h treatment, AA-5 (1) and AA-6 (2) significantly increased mitochondrial-mediated apoptosis by enhancing reactive oxygen species (ROS) with depressed mitochondrial membrane potential and caspase-9 activities. |
Target pathways |
Akt pathway |
IC50 |
14.80 µM against MCF-7
10.22 µM against MCF-7/ADM |
Potency |
Therefore, AA-5 (1) and AA-6 (2) may be effective anti-tumor and reversal agents for the further development of therapeutics against MDR breast cancer. |
Cell line/ mice model |
MCF-7, MCF-7/ADM |
Additional information |
Therefore, AA-5 (1) and AA-6 (2) may be effective anti-tumor and reversal agents for the further development of therapeutics against MDR breast cancer. |
PubChem ID |
50908449 |
Additional PMIDs |
NA |
Additional sources of information |
https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:577065-1 |
Safety |
NA |